Indeed, it has been reported that aromatase inhibitors may promote a cytotoxic polarization of tumor immune microenvironment by increasing CD8/FOXP3 T cell ratio, thus providing an appealing rationale to test combination strategies consisting of cytotoxic agents, endocrine therapy and ICIs [39, 40]. This evidence concerns the gene CD8A and neoplasm.